SWHR convened an interdisciplinary HPV Vaccine Education Working Group of public health researchers and professionals, community leaders, and health care providers to discuss how to eliminate barriers to HPV vaccine confidence, access, and uptake through the development of educational materials designed to reach women.
The Value of Diagnostics within Women’s Health series in 2022 featured six public forums that sought to highlight the role of screening and diagnostics throughout a woman’s lifespan.
The Infectious Diseases Network meeting in fall 2022 covered the role of education in vaccine uptake and renewed hope for the human papillomavirus (HPV) vaccination rate in the United States.
SWHR captured insights from a closed roundtable meeting and a public forum on HPV-related disease prevention, in a new Journal of Women’s Health article, “Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.”
The Society for Women’s Health Research (SWHR) published a paper in the Journal of Women’s Health, capturing the current landscape […]
SWHR hosted a virtual public forum on the need for innovation in HPV-related disease screening and treatment for women.
Many women have been hesitant or unable to attend health care visits because of the COVID-19 pandemic, leading to thousands of missed annual wellness visits, vaccinations, and cancer screenings.
At an SWHR roundtable, experts and patients identified gaps in research, clinical practice, policy, and education related to HPV-associated diseases.